TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages

被引:53
作者
Takano, Tomomi [1 ]
Hohdatsu, Tsutomu [1 ]
Toda, Ayako [1 ]
Tanabe, Maki [1 ]
Koyama, Hiroyuki [1 ]
机构
[1] Kitasato Univ, Sch Vet Med & Anim Sci, Dept Vet Infect Dis, Towada, Aomori 034, Japan
关键词
FIP; ADE; TNF-alpha; fAPN;
D O I
10.1016/j.virol.2007.02.006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The pathogenicity of feline infectious peritonitis virus (FIPV) is known to depend on macrophage tropism, and this macrophage infection is enhanced by mediation via anti-S antibody (antibody-dependent enhancement, ADE). In this study, we found that TNF-alpha production was increased with viral replication in macrophages inoculated with a mixture of FIPV and anti-S antibody, and demonstrated that this culture supernatant had feline PBMC apoptosis-inducing activity. We also demonstrated that the expression level of the FIPV virus receptor, feline aminopeptidase N (fAPN), was increased in macrophages of FIP cats. For upregulation of TNF-alpha and fAPN in macrophages, viral replication in macrophages is necessary, and their expressions were increased by ADE of FIPV infection. It was demonstrated that a heat-resistant fAPN-inducing factor was present in the culture supernatant of FIPV-infected macrophages, and this factor was TNF-alpha: fAPN expression was upregulated in recombinant feline TNF-alpha-treated macrophages, and FIPV infectivity was increased in these macrophages. These findings suggested that FIPV replication in macrophages increases TNF-alpha production in macrophages, and the produced TNF-alpha acts and upregulates fAPN expression, increasing FIPV sensitivity. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:64 / 72
页数:9
相关论文
共 34 条
  • [31] Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets
    Weingartl, H
    Czub, M
    Czub, S
    Neufeld, J
    Marszal, P
    Gren, J
    Smith, G
    Jones, S
    Proulx, R
    Deschambault, Y
    Grudeski, E
    Andonov, A
    He, RT
    Li, Y
    Copps, J
    Grolla, A
    Dick, D
    Berry, J
    Ganske, S
    Manning, L
    Cao, JX
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (22) : 12672 - 12676
  • [32] Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses
    Yang, ZY
    Werner, HC
    Kong, WP
    Leung, K
    Traggiai, E
    Lanzavecchia, A
    Nabel, GJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) : 797 - 801
  • [33] HUMAN AMINOPEPTIDASE-N IS A RECEPTOR FOR HUMAN CORONAVIRUS-229E
    YEAGER, CL
    ASHMUN, RA
    WILLIAMS, RK
    CARDELLICHIO, CB
    SHAPIRO, LH
    LOOK, AT
    HOLMES, KV
    [J]. NATURE, 1992, 357 (6377) : 420 - 422
  • [34] Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: Involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha
    Yonezawa, A
    Cavrois, M
    Greene, WC
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (02) : 918 - 926